Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings Ltd. (NYSE: NU) — the parent of Nubank — closed Friday, Dec. 12, 2025 at about $16.90, ending a steadier week after early-December volatility. Investing.com For investors tracking NU stock into next week, the story is less about a single earnings headline (Nu’s next results are still months away) and more about a regulatory-driven banking license push in Brazil, a fresh growth milestone in Colombia, and a macro backdrop dominated by Latin American interest-rate signals. Reuters+3SEC+3Nu International+3 NU stock performance this week: grinding higher after the Dec. 5 drop After a sharp selloff on Dec. 5 (a session
14 December 2025
··
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close). Destiny Tech100 Inc. (NYSE: DXYZ) just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private tech leaders. But DXYZ isn’t a conventional operating company stock. It’s a closed-end management investment company built to hold a portfolio of late-stage private tech names, and it can trade far away from the value of its underlying assets (NAV). Destiny+1 Below is a detailed, publication-ready breakdown of this week’s move (Dec. 8–12), the most important news from the last
14 December 2025
··
Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (after market close) Altria Group, Inc. (NYSE: MO) ended the week on a quiet but steady note—closing at $58.75 on Friday, Dec. 12, extending a five-session grind higher from $58.11 on Dec. 8 (about +1.1% for the week). Investing.comWhile the broader market sold off on Friday, Altria’s shares were essentially unchanged on the day—an example of why income-focused investors often treat the tobacco giant as a defensive holding. MarketWatch+1 But “quiet price action” doesn’t mean “no catalysts.” Two company headlines landed back-to-back in the last few days—a leadership succession plan and a fresh dividend declaration—and they
14 December 2025
·
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire+1 The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after swinging through a wide intraday range and printing exceptionally heavy volume. After-hours trading showed a modest rebound. StockAnalysis Below is a detailed breakdown of the latest Milestone Pharmaceuticals news, this week’s trading story, forecasts and analyst targets, and the week-ahead
14 December 2025
··
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at $2,015.89, finishing a choppy week that featured a sharp selloff on Wednesday and a rebound attempt into the close. StockAnalysis The headline catalyst in the final days of the week wasn’t earnings—it was automation and capital markets. MercadoLibre announced a
14 December 2025
·
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience pipeline. Yahoo Finance+2MarketBeat+2 For investors, the near-term story remains a familiar one: ABBV’s share price is being pulled between defensive-dividend appeal (especially in an uncertain macro backdrop) and the market’s ongoing debate over how durable AbbVie’s post-Humira growth engine will be—driven mainly by Skyrizi and Rinvoq, plus a deepening pipeline. AbbVie News Center+1 ABBV stock this week: Where AbbVie shares
14 December 2025
·
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) ended the week near $5.10 after a sharp Thursday drop. Here’s what moved MPW stock this week, the latest tenant and legal headlines, analyst forecasts, and the key catalysts to watch in the week ahead. Medical Properties Trust, Inc. (NYSE: MPW) finished the Dec. 8–12 trading week under renewed pressure, closing Friday around $5.10 after a volatile stretch that included a sharp selloff on Thursday. Finviz For investors, MPW remains a story of two forces pulling in opposite directions: Below is a full “this week / week ahead” briefing—written for readers tracking MPW stock day
14 December 2025
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at $81.65. Yahoo Finance That close caps a volatile, news-packed week in which the company leaned hard into a single message for investors: power demand is accelerating, and the fastest-growing customers are increasingly AI and data-center developers—a trend NextEra believes can translate into multi-year earnings and dividend growth. NextEra Energy Investor Relations+1 Below is a complete, publication-ready breakdown of what moved
14 December 2025
····
Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Updated: Friday, December 12, 2025 (U.S. market close)Company: The Coca-Cola Company (NYSE: KO) Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors are weighing a leadership transition set for 2026, the company’s steady “defensive” profile, and the next set of catalysts: a dividend payment on Monday (Dec. 15) and a data-heavy U.S. economic calendar that could influence interest rates—and by extension the appeal of dividend-focused stocks like KO. StockAnalysis+2StockAnalysis+2 KO stock recap: what happened this week (Dec. 8–Dec. 12) Coca-Cola shares closed
14 December 2025
·
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs: interest rates and bond yields. StockAnalysis Below is what moved Realty Income stock this week, what the latest announcements mean for income-focused investors, and what to watch in the week ahead as markets digest the Fed’s latest move and year-end positioning ramps up. Realty Income stock this week: a choppy slide despite positive company news Realty Income ended Friday, Dec.
14 December 2025
··
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts+1 It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale, expansion strategy, and a fresh round of analyst updates. Investing.com+2Barron’s+2 Below is a comprehensive, publication-ready look at what moved DoorDash stock this week, the latest DoorDash news, and the key catalysts for the week ahead (Dec. 15–19). DoorDash stock price
13 December 2025
Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025 Altria Group, Inc. (NYSE: MO) ended Friday, Dec. 12, at $58.75, extending a string of modest daily gains and leaving the stock up roughly ~1%–1.3% over the last five sessions—a steady week for a high-yield, defensive name as investors digested two company-specific headlines: a CEO succession announcement and a fresh quarterly dividend declaration. StockAnalysis+2Reuters+2 With the market increasingly sensitive to interest rates and yield-based positioning, Altria’s “bond proxy” characteristics (plus its dividend that remains among the richer payouts in large-cap U.S. equities) keep MO on the watchlist for income-focused investors heading into the final full trading
13 December 2025
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile start to the week, Nike shares finished Friday at $67.47 (down 0.40% on the day) and ended the week up about 2.4% versus last Friday’s close. StockAnalysis The setup now is a familiar one for investors: a globally dominant brand in the middle of a turnaround (“Win Now”), facing tariff-driven cost pressure, digital and direct-to-consumer (DTC) traffic questions, and intensifying
13 December 2025
···
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
·
ADP Stock (NASDAQ: ADP) Update: What Drove Automatic Data Processing Shares This Week — and What to Watch Next Week (Updated Dec. 12, 2025)

ADP Stock (NASDAQ: ADP) Update: What Drove Automatic Data Processing Shares This Week — and What to Watch Next Week (Updated Dec. 12, 2025)

Automatic Data Processing, Inc. (ADP) stock finished the week on a stronger note even as broader markets pulled back. Shares closed Friday, Dec. 12, 2025 at $266.10, up 1.18% on the day and marking a third consecutive session of gains. MarketWatch Still, ADP remains well below its 52-week high near $329.93 (June 6), keeping the stock’s pullback narrative in focus heading into a data-heavy week for U.S. markets. MarketWatch Below is a full, updated look at ADP stock this week, the most important ADP headlines from the last several days, Wall Street forecasts, and the week-ahead catalysts that could move
13 December 2025
·
Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers Group, Inc. (Nasdaq: IBKR) closed Friday, Dec. 12 at $64.15, ending a volatile session down about 2.9% after swinging from roughly $66.00 at the high to $62.58 at the low. StockInvest The week’s price action landed as investors tried to square three overlapping storylines: (1) a shifting U.S. rate outlook after the Federal Reserve’s latest move, (2) company headlines that broaden Interactive Brokers’ global footprint, and (3) rising attention on how brokers may integrate crypto rails—most notably via stablecoins—into traditional brokerage funding. Below is what mattered for IBKR stock this week, what analysts are forecasting now, and what
13 December 2025
··
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the spotlight for America’s largest for-profit hospital operator. StockAnalysis+2MarketWatch+2 Below is what moved HCA stock this week, the most important HCA Healthcare news from the past several days, what analysts are forecasting now, and the key catalysts to watch in the week ahead. HCA stock this week: flat finish, big intrawEEK volatility HCA ended Friday (Dec. 12) at $484.77, up 0.50%
13 December 2025
·
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin Corporation (NYSE: LMT) wrapped up the week with a strong move higher, closing at $480.25 on Friday, December 12, 2025, extending a nine-session winning streak even as broader U.S. equities finished the day lower. MarketWatch+1 For investors tracking LMT stock into next week, the story is a mix of momentum, contract-driven visibility, and headline risk—especially around the F-35 program after Switzerland said it will trim its planned purchase to stay within budget. Reuters Below is a detailed, Google News/Discover-ready roundup of what moved Lockheed Martin stock this week, the most important news from the last several days, updated
13 December 2025
···
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Updated: Friday, December 12, 2025Ticker: Starbucks Corporation (NASDAQ: SBUX) Starbucks stock ended the week on a steadier note after a choppy stretch that included a sharp early-week dip and a rebound into Friday’s close. Heading into next week, investors are weighing three near-term forces: labor headlines (as the workers’ strike expands), operational initiatives tied to CEO Brian Niccol’s “Back to Starbucks” turnaround, and macro data that can swing consumer-facing names. SBUX closed Friday, Dec. 12 at $85.35, up modestly from last Friday’s $85.12, after falling as low as $82.28 on Tuesday before recovering across the rest of the week. Starbucks
13 December 2025
··
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025Company: CME Group Inc. (NASDAQ: CME) CME Group stock ended the week on a steadier footing after a midweek dip, closing at $273.55 on Friday, Dec. 12 (up 0.42% on the day). Finviz That finish capped a modest weekly gain driven by a familiar theme for exchange operators: volatility, volumes, and policy-driven market plumbing changes. This week’s CME story wasn’t about a single earnings headline. Instead, investors digested a fresh surge in trading activity (including record crypto participation), regulatory momentum around U.S. Treasury market clearing, and a macro backdrop that continues to feed demand for hedging
13 December 2025
·
1 … 494 495 496 497 498 … 608

Stock Market Today

Go toTop